81283 Ifnl3 gene
Also known as: IFNL3 polymorphism test, IL28B genetic testing
Interferon Lambda 3 (IFNL3) gene polymorphism analysis to predict hepatitis C treatment response and determine disease progression risk.
In Plain Language
Hepatitis C response predictor; Hepatitis C treatment planning test
Clinical Context
Identifies IFNL3 genetic variants that predict hepatitis C treatment response to interferon-based therapy. Important for treatment selection and prognosis.
RVU Information
CPT 81283 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81283?
CPT 81283 (Ifnl3 gene) is a Pathology & Lab code. Interferon Lambda 3 (IFNL3) gene polymorphism analysis to predict hepatitis C treatment response and determine disease progression risk.
Who uses CPT code 81283?
CPT 81283 is used by Pathology, Infectious Disease, Hepatology. Identifies IFNL3 genetic variants that predict hepatitis C treatment response to interferon-based therapy. Important for treatment selection and prognosis.
When is CPT 81283 used?
Identifies IFNL3 genetic variants that predict hepatitis C treatment response to interferon-based therapy. Important for treatment selection and prognosis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.